InspireMD Inc - NSPR Company Long-Term Liabilities

Graphic logo of InspireMD Inc (NSPR)

InspireMD, Inc. (NSPR) develops unique stents to protect vessels from embolism and prevent strokes. The current market quotes visualized below complement the debt data, which stands at 0.00. The premium pricing of the products is based on clinical superiority, although hospital procurement pressures are weighing on profits. Meanwhile, expansion is hindered by capital shortages, slow technology adoption by physicians, and complexities regarding insurance company reimbursements.

NSPR InspireMD, Inc.: Company Long-Term Debts in the range 07/04/2022 - 10/29/2026

Analytical breakdowns for InspireMD Corp (NSPR)

- price and consensus price forecast:
Market Price inspiremd.com|NSPR - Analyst Consensus Forecast
- market capitalization data:
Market Valuation InspireMD|NSPR - Enterprise Value
- book capitalization data:
Net Assets per Share InspireMD|NSPR - Book Capitalization|Market Capitalization to Book Value Ratio inspiremd.com|NSPR - Aggregate Company Assets
- debt and liquidity data:
Debt to Equity InspireMD, Inc.|NSPR - Long-Term Debt to Capital|Short-Term Debt to Capital Coefficient InspireMD Inc.|NSPR - Company Total Debt|Debts to Book Capitalization Ratio InspireMD|NSPR - Company Long-Term Debts|Short-Term Debt InspireMD
Basic company analysis:NSPR (inspiremd.com)
Original product of InspireMD, Inc.

Identifying fundamentally resilient assets requires an assessment of long-term liabilities, which accumulate the value of the loan portfolio and determine the balance between financial stability and return on equity. The dynamics of InspireMD, Inc. (NSPR) long-term loans and borrowings reflect the cost of debt service, which is critical for InspireMD, Inc. (NSPR) when scaling the implementation of vascular stents and managing insurance payout risks in cardiac surgery.

Direct competitors

Long-Term Debt bostonscientific.com BSX|EW: Company Long-Term Debts|RMD - Company Long-Term Liabilities|OmniPod - Company Long-Term Debts|Zimmer Biomet Holdings, Inc. (ZBH) - Long-Term Debt Volume|COO (The Cooper Companies) - Company Long-Term Debts|Company Long-Term Debts ALGN|Company Long-Term Debt Globus Medical (GMED)|Company Long-Term Debt TransMedics Group (TMDX)|Company Long-Term Debts ATEC|AORT - Long-Term Debt Volume|Company Long-Term Liabilities Enovis Corporation|IART - Long-Term Liabilities|Company Long-Term Debts ESTA|Beta Bionics, Inc. (BBNX) - Long-Term Debt|Company Long-Term Debts Iradimed (IRMD)|Company Long-Term Indebtedness Embecta Health (EMBC)|Tandem Diabetes Care (TNDM) - Company Long-Term Liabilities|Company Long-Term Loans and Borrowings AXGN (axogeninc.com)|SI-BONE - Company Long-Term Debt|Company Long-Term Liabilities Orthofix Medical OFIX|BVS (Bioventus Corp) - Company Long-Term Debts|KIDS - Long-Term Debt|Company Long-Term Debts Treace Medical Concepts|blade.com (SRTA) - Company Long-Term Indebtedness|CARL: Company Long-Term Debts|Long-Term Debt Volume RxSight Inc|Company Long-Term Debts CLPT (ClearPoint Neuro, Inc.)|Company Long-Term Liabilities Stereotaxis Corporation (STXS)|Company Long-Term Debts STIM (Neuronetics, Inc.)|sightsciences.com - Company Long-Term Debts|OBIO - Company Long-Term Debt|Anika Therapeutics (ANIK) - Company Long-Term Debt|Company Long-Term Liabilities zhjmedical.com ZJYL|Vivani Medical (VANI) - Company Long-Term Loans and Borrowings|Company Long-Term Debts XTNT (Xtant Medical Holdings, Inc.)|Long-Term Debt NMTC|MODD: Company Long-Term Debt|Long-Term Indebtedness Myomo Inc. MYO|Company Long-Term Liabilities COCH (Envoy Medical, Inc)|Company Long-Term Debts Vivos Therapeutics Inc VVOS|Company Long-Term Debts NVNO (enVVeno Medical)|SINT: Long-Term Debt Volume|Company Long-Term Debt Tenon Medical (TNON)|LFWD (ReWalk Robotics) - Long-Term Liabilities|Company Long-Term Debt AMIX|Company Long-Term Liabilities INVO Fertility Corp|Bone Biologics - Company Long-Term Debts|Long-Term Debt AXNX (axonics.com)|BIOL - Company Long-Term Debt|DYNT - Company Long-Term Indebtedness|Company Long-Term Liabilities Paragon 28 Corp FNA|INVO - Amount of Long-Term Liabilities